Showing results (401-410 of 1,343) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|October 29, 2014
Management and return of incidental genomic findings in clinical trialsC Ayuso, J M Millan, R Dal-ReThe Pharmacogenomics Journal|October 28, 2015
Predictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic studyE Rumiato, A Brunello, S Ahcene-Djaballah, et al.The Pharmacogenomics Journal|October 28, 2015
Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohortT M Dodgen, C De J Labuschagne, A van Schalkwyk, et al.The Pharmacogenomics Journal|March 23, 2016
Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumabF S Falvella, C Cremolini, R Miceli, et al.The Pharmacogenomics Journal|March 23, 2016
Mechanisms of the placebo effect in pain and psychiatric disordersR D Holmes, A K Tiwari, J L KennedyThe Pharmacogenomics Journal|April 20, 2016
Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patientsN Ben Fredj, R Gam, E Kerkni, et al.The Pharmacogenomics Journal|April 20, 2016
Determinants of Gefitinib toxicity in advanced non-small cell lung cancer (NSCLC): a pharmacogenomic study of metabolic enzymes and transportersY Ma, S Xin, M Huang, et al.The Pharmacogenomics Journal|August 11, 2018
Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugsJames R Perkins, Marialbert Acosta-Herrera, María C Plaza-Serón, et al.The Pharmacogenomics Journal|August 1, 2018
Two common mutations within CYP2C19 affected platelet aggregation in Chinese patients undergoing PCI: a one-year follow-up studyZhifu Wang, Zhaohui Liu, Wenyao Wang, et al.The Pharmacogenomics Journal|October 7, 2021
A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxinNegin Soroush, Albert-Jan Aarnoudse, Maryam Kavousi, et al.Pageof 135